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Endometriosis is a gynecologic disorder characterized by the
presence of endometrial-like tissues outside of the uterine cavity,
predominantly on the ovary and pelvic peritoneum [1]. Endometri-
osis has been estimated to affect approximately 10e15% of women
during menacme, 50e60% of women and teenage girls with pelvic
pain, and up to 50% of women affected by infertility [1,2]. There is
no easy way to diagnose this condition [1]. Patients with clinically
suspected endometriosis often must undergo laparoscopy, which is
considered the gold standard procedure in the diagnosis of endo-
metriosis [1,2]. Although laparoscopy is a minimally invasive proce-
dure, it requires general anesthesia and surgical skills when carried
out, with potential complications and procedural costs [1]. Thus,
the identiﬁcation of a non-invasive diagnostic approach would be
advisable to detect early endometriosis for both physicians and
women alike, in order to focus the use of laparoscopy only on
women who are highly suspected of having endometriosis. The
mechanism responsible for endometriosis has not yet been fully
elucidated [1]. Endometriosis is a polygenic diseasewith a complex,
multifactorial etiology [1e3]. Immunological alterations have been
proposed to contribute to the physiopathogenesis of endometriosis
and its sequelae [2,4e6]. It is widely accepted that endometriosis is
an inﬂammatory process [2]. It has been linked to altered immune
cell function, immune cell numbers, and elevated inﬂammatory cy-
tokines, including interferon-g (IFN-g), implying a shift towards a
Th1 immune response pattern [2,7]. In particular, an enhanced
expression of resident leukocyte IFN-g mRNA has been demon-
strated in endometriosis [4]. It has also been reported that ectopic
mononuclear cells of women with adenomyosis produce higher
levels of IFN-g than mononuclear cells of normal endometrium
[8]. Furthermore, an increased number of T cells, expression of
IFN-g, and enhanced antigen presentation have also been described
in ectopic in comparison to eutopic endometrium [5]. Various
studies have recognized that patients with endometriosis have
higher levels of IFN-g compared to healthy controls [2e4,6,7]. It
has been demonstrated that IFN-g levels are signiﬁcantly greater
in the peritoneal ﬂuid of womenwith endometriosis in comparison
to patients without the disease [2e4,6]. Intriguingly, IFN-g has been
correlated with different stages of endometriosis [7]. Concordantly,
a dysfunction in Th1 immune responses pattern conditioning
enhanced IFN-g in the peritoneal ﬂuid has been strongly correlated
with deep inﬁltrating endometriosis [2]. Interestingly, it has been
shown that peritoneal ﬂuid obtained from patients with endome-
triosis seems to enhance IFN-g activity [9]. This all leads us to hy-
pothesize that the determination of IFN-g released by activated T
cells and mononuclear cells might serve as a peripheral bloodhttp://dx.doi.org/10.1016/j.tjog.2012.11.005
1028-4559/Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Publishedbiomarker for early diagnosis of endometriosis, discriminating
between women with endometriosis and controls. In vitro IFN-g
release assays, such as QuantiFERON-TB Gold, have been
developed to identify latent Mycobacterium tuberculosis (Mtb)
infection [9].
Tuberculosis is a major public matter and is the most important
single infectious cause of mortality and morbidity worldwide [9]. It
has been reported that approximately one third of the world’s pop-
ulation is infected with the causative bacterium Mtb and is at risk
for developing active tuberculosis [10]. Similarly to endometriosis,
corroborating evidence has shown the importance of IFN-g in the
protective immunity against mycobacterial infections [4]. More-
over, mutations that interfere with IFN-g production have been
associated with the clinical spectrum and the outcome of active
tuberculosis [10]. The QuantiFERON assay is an indirect test that
documents IFN-g inwhole blood stimulatedwithMbt-speciﬁc pep-
tide antigens with high sensitivity and speciﬁcity [11]. A similar
assay might also be valuable for diagnosing latent endometriosis,
particularly in adolescent girls. The recognition process involving
the generation and the secretion of IFN-g might be obtained
upon stimulation with the supernatant of peritoneal ﬂuid from
women with endometriosis as antigen cocktail, given the availabil-
ity of banked endometriotic peritoneal ﬂuid. In conclusion, the
implementation of a modiﬁed QuantiFERON assay might represent
a promising nonsurgical approach for predicting susceptibility to
endometriosis. In addition, IFN-g release assay based on the
QuantiFERON test systemmay allow gynecologists to monitor their
patients over time. In this regard, changes in QuantiFERON results
might be considered as a tool to verify the progression of the dis-
ease and the efﬁcacy of different treatment regimens for endome-
triosis. Research studies are needed to develop this procedure
deﬁning its predictive value and potential utility in improving diag-
nostic and surveillance care of endometriosis.
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